U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
BI-836826
LB090AB8DB
Investigational
General
Names
5
Classification
3
Identifiers
3
Related Substances
1
BI-836826
LB090AB8DB
Investigational
General
Approval Year
Unknown
149,124
Names
5
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
BI 836826
Preferred Name
English
BI-836826
Code
English
MAB 37.1
Common Name
English
ANTI-CD37 MONOCLONAL ANTIBODY BI 836826
Common Name
English
BI 836826 [WHO-DD]
Common Name
English
Showing 1 to 5 of 5 entries
Previous
1
Next
Classification
3
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of chronic lymphocytic leukemia (CLL).
FDA ORPHAN DRUG
451514
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Antineoplastic Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Antineoplastic Biological Agent
[C129821]
Antineoplastic Antibody
NCI_THESAURUS
C129822
Showing 1 to 3 of 3 entries
Previous
1
Next
Identifiers
3
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
FDA UNII
LB090AB8DB
PRIMARY
SMS_ID
300000041427
PRIMARY
NCI_THESAURUS
C122833
PRIMARY
Showing 1 to 3 of 3 entries
Previous
1
Next
Related Substances
1
ACTIVE MOIETY
LB090AB8DB
BI-836826
